Search Results - M. M. Shmarov

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    New recombinant rabies vaccines

    New recombinant rabies vaccines by E. S. Sedova, M. M. Shmarov

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)

    DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2) by L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov

    Published 2017-08-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)

    DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1) by L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov

    Published 2017-05-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Protecting Mice from H7 Avian Influenza Virus by Immunisation with a Recombinant Adenovirus Encoding Influenza A Virus Conserved Antigens

    Protecting Mice from H7 Avian Influenza Virus by Immunisation with a Recombinant Adenovirus Encoding Influenza A Virus Conserved Antigens by E. S. Sedova, L. V. Verkhovskaya, E. A. Artemova, D. N. Shcherbinin, A. A. Lysenko, I. A. Rudneva, A. V. Lyashko, S. A. Alekseeva, I. B. Esmagambetov, T. A. Timofeeva, M. M. Shmarov

    Published 2020-03-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Safety, reactogenicity, and immunogenicity of a viral vector vaccine against influenza A: Phase I open clinical trial

    Safety, reactogenicity, and immunogenicity of a viral vector vaccine against influenza A: Phase I open clinical trial by M. M. Shmarov, S. V. Alekseeva, N. A. Dovzhenko, A. S. Bandelyuk, I. B. Esmagambetov, D. N. Shcherbinin, L. V. Verkhovskaya, S. V. Volchihina, Ya. V. Simakova, V. F. Babira, D. Y. Logunov, A. L. Gintsburg

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Method for obtaining recombinant antibodies produced by a cell line transduced with recombinant adenoviruses

    Method for obtaining recombinant antibodies produced by a cell line transduced with recombinant adenoviruses by E. S. Sedova, D. N. Shcherbinin, A. S. Bandelyuk, L. V. Verkhovskaya, N. Yu. Viskova, E. D. Avdonina, V. V. Prokofiev, E. I. Ryabova, I. B. Esmagambetov, K. A. Pervoykina, E. A. Bogacheva, A. A. Lysenko, M. M. Shmarov

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Production of the recombinant hemagglutinin protein of the swine influenza virus A/H1N1 and analysis of its physicochemical and antigenic properties

    Production of the recombinant hemagglutinin protein of the swine influenza virus A/H1N1 and analysis of its physicochemical and antigenic properties by E. D. Avdonina, K. A. Pervoykina, L. V. Verkhovskaya, D. N. Shcherbinin, N. Yu. Viskova, I. S. Kruzhkova, M. A. Ilina, L. V. Kudriavtseva, L. V. Kolobukhina, M. M. Shmarov, N. A. Antipyat, A. L. Gintsburg, I. N. Tyurin

    Published 2025-05-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Erratum to the article “Production of the recombinant hemagglutinin protein of the swine influenza virus A/H1N1 and analysis of its physicochemical and antigenic properties”

    Erratum to the article “Production of the recombinant hemagglutinin protein of the swine influenza virus A/H1N1 and analysis of its physicochemical and antigenic properties” by E. D. Avdonina, K. A. Pervoykina, L. V. Verkhovskaya, D. N. Shcherbinin, N. Yu. Viskova, I. S. Kruzhkova, M. A. Ilina, L. V. Kudriavtseva, L. V. Kolobukhina, M. M. Shmarov, N. A. Antipyat, A. L. Gintsburg, I. N. Tyurin

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: